Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-018314
Filing Date
2024-06-27
Accepted
2024-06-27 16:05:55
Documents
2
Period of Report
2024-06-27

Document Format Files

Seq Description Document Type Size
1 form3-06272024_080652.html 3  
1 form3-06272024_080652.xml 3 11850
2 ex24-06272024_080655.htm EX-24 4370
  Complete submission text file 0001415889-24-018314.txt   17839
Mailing Address C/O ALUMIS INC. 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Hardiman Roy C. (Reporting) CIK: 0001506218 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42143 | Film No.: 241079172

Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Issuer) CIK: 0001847367 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)